Admission Date:  [**2122-7-21**]       Discharge Date:  [**2122-7-23**]  Date of Birth:   [**2050-4-2**]       Sex:  Service:  HISTORY OF PRESENT ILLNESS:  Mr. [**Known lastname **] is a 72-year-old with a history of diastolic heart failure, hypertension and myelodysplastic syndrome (MDS) of refractory anemia with [**Last Name (un) 43256**] cytoblast type who presented initially to [**Hospital3 1280**] Hospital on [**2122-7-19**] with several days of abdominal pain, diarrhea, poor oral intake, nausea, vomiting.
A right IJ catheter was placed.
He underwent one episode of leukophoresis but subsequently he transferred to [**Hospital1 346**] for further treatment including possible salvage chemotherapy.
Initially seen by Dr. [**Last Name (STitle) 43257**] in [**2122-1-13**], anemia treated initially with Epogen, subsequently started on GMCSF later Thalidomide.
FIO2 96% on two liters nasal cannula.
7.45, 31 and 142 on two liters nasal cannula.
He was maintained on oxygen by nasal cannula to support his blood oxygenation.
Treatment of tumorlysis and also treated with Hydroxyurea.
Pathology service was consulted to continue his leukophoresis and they did so on [**7-21**] with subsequent decline in white blood count to 88,700.
Hematology/Oncology recommended sending peripheral blood and bone marrow for studies including cytogenetics to assist with diagnosis and therapeutic options.
The patient underwent second episode of leukophoresis at [**Hospital1 69**] (third episode overall) on the 10th with some agitation during this procedure.
The patient's white blood count nadir at 57,000 following leukophoresis on the 10th but subsequently climbed to 162,000 by [**7-23**].
The patient started leukophoresis at [**Hospital1 1444**] on [**2122-7-23**] and bone marrow results were pending when discussions were held with the family over goals of care and treatment options.
However, upon further discussions with the family (as patient's mental status changes prevented him from understanding/expressing his decisions about medical care) the patient's family and Intensive Care Unit/Hem/Onc teams decided that given poor prognosis and clinical circumstances the patient's goals would be more consistent with signs of further leukophoresis and further workup of medical condition were discontinued and the patient received 1 mg of Morphine for discomfort.
